I-Remdesivir Intermediate CAS 1354823-36-1 COVID-19 N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester

Inkcazelo emfutshane:

N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester

CAS: 1354823-36-1

Umbindi we-Remdesivir (CAS 1809249-37-3) kunyango lwe-COVID-19

Umgangatho ophezulu, iMveliso yoRhwebo

Inquiry: alvin@ruifuchem.com


Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Iipropati zeMichiza:

Igama leMchiza N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester
Izithethantonye I-Remdesivir ePhakathi;I-Remdesivir Side Chain;I-Remdesivir p-NitroPhenoxy L-Alanine Ukungcola;Ukungcola kwe-Remdesivir 4;I-Remdesivir-002;(S)-2-Ethylbutyl 2-(((S)-(4-nitrophenoxy)(phenoxy)-phosphoryl)-amino)propanoate
Inombolo yeCAS 1354823-36-1
Inombolo yeCAT RF-PI297
Ubume beStokhwe Kwi-Stock, iMveliso yeMveliso ukuya kumakhulu eeKilogram
Ifomula yeemolekyuli I-C21H27N2O7P
Ubunzima beMolekyuli 450.42
Uphawu Ruifu Chemical

Iinkcukacha:

Into Iinkcukacha
Imbonakalo Mhlophe ukuya Phantse uMhlophe
Ukuchongwa IR, HPLC
Ilahleko ekomisweni ≤1.0%
Ukungacoceki Okukodwa ≤0.50%
Iintsimbi ezinzima ≤20ppm
Ubunyulu ≥98.0%
Umgangatho woVavanyo Umgangatho woShishino
Ukusetyenziswa Umbindi weRemdesivir (CAS 1809249-37-3);I-COVID 19

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, igubu lekhadibhodi, 25kg/Igubu, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.

Izinto eziluncedo:

1

FAQ:

Isicelo:

N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester (CAS 1354823-36-1, eyaziwa ngokuba yi-Remdesivir Ukungcola 4) yi-phosphoramidate sidechain esetyenziselwa ukulungiswa kwe-Remdesivir (CAS . 1809249-37-3, GS-5734), elichiza eliyinoveli lophando lwe-antiviral ekuqaleni kunyango lwe-Ebola virus isifo kunye nosulelo lwentsholongwane ye-Marburg kwaye emva koko kwafunyaniswa ukuba ibonisa umsebenzi we-antiviral ngokuchasene ne-coronavirus (umz. SARS-Cov-2/ I-covid 19).Ngexesha lokuqhambuka kwesifo esitsha seCoronavirus sika-2019 (COVID-19), iRemdesivir (CAS 1809249-37-3) yenye yeemveliso zophando ezinxulumene ne-COVID-19.I-Remdesivir, ethengiswa phantsi kwegama lebhrendi iVeklury, liyeza elibanzi lokulwa neentsholongwane eliphuhliswe yinkampani yebiopharmaceutical yaseGiliyadi iSayensi.Isetyenziswa ngesitofu emithanjeni.Ngexesha lobhubhani we-COVID-19, i-Remdesivir yamkelwa okanye yagunyaziswa ukuba isetyenziswe ngokungxamisekileyo ukunyanga i-COVID-19 kumazwe amalunga nama-50.Izikhokelo ezihlaziyiweyo ezivela kuMbutho wezeMpilo weHlabathi ngoNovemba ka-2020 zibandakanya isindululo esinemiqathango ngokuchasene nokusetyenziswa kwe-Remdesivir kunyango lwe-COVID-19.

Bhala umyalezo wakho apha kwaye uwuthumele kuthi